Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

US President Joe Biden has completed a round of radiation therapy as part of his prostate cancer treatment, according to ...

Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2 ...

Dairy products offer nutrients but overconsumption poses health risks. Excessive intake can cause digestive upset, bloating, ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

A new branch of a national cancer charity has opened in the grounds of a town's hospital. The Maggie's Centre will offer ...

High profile politicians have thrown their weight behind calls to screen at-risk men for prostate cancer, but are potential ...

Stephen Freedland, MD, of Cedars-Sinai, discussed enzalutamide and leuprolide's potential to improve overall survival without ...